Glooma develops the SenseGlove, a sensor-equipped glove paired with a mobile app that enables portable, at-home breast tissue screening using machine-learning algorithms to complement self-exams and detect early changes. The device is intended as a health monitoring tool rather than a diagnostic device and is currently in pre-sale on the company website. Glooma has completed its pre-seed financing and is using the funds to make the SenseGlove market-ready and to establish the foundations for commercial expansion. The company is headquartered in Braga. Management says the funding will help scale the product so it can reach more women and support planned international expansion, including the U.S. market. No operating metrics (revenue/users) were disclosed in the article.

Total raised

$0M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2023